Oncostatin M is associated with a higher risk profile and predicts a worse outcome in patients with STEMI

21 March 2026 (16:25 - 17:25)
Organised by: Logo
Congress Presentation Part of: Inflammation, biomarkers, and metabolism in acute coronary syndrome Biomarkers ACVC Premium Access ESC Acute CardioVascular Care 2026 Association for Acute CardioVascular Care (ACVC)